DENVER/March 29, 2022 – Morris Animal Foundation is now accepting proposals for studies focused on curative treatments for osteosarcoma in Saint Bernards and other giant-breed dogs. Grant applications are due by June 13, 4:59 p.m. ET.
This RFP is funded by a donor who lost her beloved Saint Bernard dog to osteosarcoma, the most common bone tumor in dogs. In memory of her dog, the donor is partnering with the Morris Animal Foundation through its Donor-Inspired Study program to support research that will lead to curative treatments for osteosarcoma in giant-breed dogs, improving survival and quality of life.
This request for proposals (RFP) is the first phase of a two-phase process. This first phase will award seed funding to collaborative, interdisciplinary groups working on treatment approaches that have strong translational potential leading to clinical impact. Approaches may encompass methods of early diagnosis, if appropriate. Successful proposals will include novel approaches (not previously funded) and require establishing technical merit and feasibility.
Projects must be focused on clinical impact for Saint Bernard dogs and other giant-breed dogs in North America. Studies targeting other breeds or other geographic regions will not be considered. Proposed use of laboratory animals in research studies will not be accepted under this RFP.
Academic/industry partnerships are welcome, provided there is both financial and in-kind input and recognition that Morris Animal Foundation contracts include royalty agreements.
The maximum project duration is 18 months, and successful projects funded from this first RFP may be invited to compete for a larger award in the second-phase RFP, pending progress review.
Applications will be reviewed and rated, based on impact and scientific rigor, by a scientific advisory board, made up of subject matter experts. Interested researchers can learn more and apply for the award at Morris Animal Foundation.
Scientific Advisory Board
- Brian Flesner, DVM, MS, DACVIM, University of Pennsylvania
- Anita Rogic, MSc, MBA, University of Missouri
- Christopher Pinard, DVM, DVSc, DACVIM, VCA Toronto, Canada
- Ira Gordon, DVM, DACVR (Radiation Oncology), Ethos Veterinary Health
- Manish Neupane, DVM, PhD, AstraZeneca
- Nick Bacon, MA, VetMB, CertVR, CertSAS, DiplECVS, DACVS, FRCVS, Fitzpatrick Referrals, Surrey UK
- Valerie Poirier, DVM, DACVIM, DACVR, MANZCVS, University of Guelph, Canada
- Wesley Wierson, PhD, Leah Labs
- Greg Krane, DVM PhD, DACVP, Moderna/Tufts University
About Morris Animal Foundation
Morris Animal Foundation’s mission is to bridge science and resources to advance the health of animals. Founded in 1948 and headquartered in Denver, the Foundation has invested more than $142 million to date in nearly 3,000 studies to advance the health and well-being of animals around the world.